Ozempic fatigue and constipation: what the nutrition advice gets right

What did @dranitzastaub actually say?

Here's the problem: the transcript provided for this video is largely unintelligible. What was captured reads as garbled phonetic fragments, not coherent Spanish or any identifiable language. So the honest answer is we cannot verify what @dranitzastaub actually said word for word. What we can work with is the caption, which lays out a clear enough argument: people on Ozempic experience low energy and constipation because they're not eating well, and the fix is hydration, protein, and vegetables filling half the plate.

The caption states, "El medicamento no hace magia solo" — the medication doesn't work magic alone. That framing is worth examining on its own merits, because it's both a reasonable clinical position and, depending on what came next in the video, potentially an oversimplification of why GLP-1 side effects actually occur.

Does the science back this up?

Mostly, yes. The claim that poor nutrition on semaglutide leads to muscle loss and blunted results has solid backing. A 2021 trial by Wilding et al. in the New England Journal of Medicine found that semaglutide users lost a meaningful proportion of lean mass alongside fat, a pattern that gets worse when protein intake drops because the drug suppresses appetite broadly, not selectively.

On constipation specifically: the caption frames it as a nutrition problem, but that's only part of the picture. GLP-1 receptor agonists slow gastric emptying directly, through pharmacological action on the gut. A 2022 review by Mehta et al. in Obesity Reviews noted that gastrointestinal side effects including constipation affect roughly 24 percent of semaglutide users and are largely dose-dependent, not purely diet-dependent. Hydration and fiber help, but they don't eliminate the underlying mechanism.

The protein advice lines up with emerging consensus. Carbone and Pasiakos (2019, Advances in Nutrition) found that higher protein intake during caloric restriction preserves lean mass, which matters a lot when GLP-1 drugs are doing heavy appetite suppression.

What did they get wrong (or right)?

Let's give credit first. Telling people on Ozempic to prioritize protein and vegetables is genuinely good advice, and it's the kind of practical guidance that often gets skipped in the rush to celebrate weight loss numbers. The "half a plate of vegetables" framing is consistent with standard dietary guidance and not remotely harmful.

Where the caption falls short is in framing constipation and fatigue almost entirely as self-inflicted nutrition problems. That risks making patients feel responsible for side effects that are partly just pharmacology. A patient who eats perfectly can still experience constipation on semaglutide because the drug slows gut motility. Telling someone "si no comes bien" implies they're doing something wrong when sometimes the drug is just doing what it does.

Fatigue is even more complicated. Low energy on GLP-1 therapy can reflect rapid caloric restriction, micronutrient gaps, or in some cases, thyroid or adrenal factors that have nothing to do with vegetable intake. The caption doesn't acknowledge that complexity, which is a real gap for a health professional platform with nearly half a million views.

What should you actually know?

If you're on semaglutide or a similar GLP-1 drug and feeling exhausted or constipated, nutrition is a reasonable place to start investigating. Aim for at least 1.2 grams of protein per kilogram of body weight daily, based on guidance from Leidy et al. (2015, American Journal of Clinical Nutrition). That number is hard to hit when your appetite is suppressed, which is exactly why it requires deliberate effort, not just eating when you feel like it.

Constipation that doesn't respond to increased fiber and fluid intake, or that is severe, should be reported to whoever is managing your prescription. It's not always a sign you need more broccoli. In some cases, dose timing or adjustments to the escalation schedule can help, but that's a clinical conversation, not a TikTok fix.

Muscle loss is a real risk on GLP-1 therapy and it matters beyond aesthetics. Lean mass affects metabolic rate, insulin sensitivity, and long-term weight maintenance. Resistance training alongside adequate protein is the most evidence-supported approach to preserving it, as outlined in a 2023 analysis by Seimon et al. in the International Journal of Obesity. That piece of the puzzle didn't make it into the caption, and it should have.